patients with diagnosed solid tumor

Criteria

Inclusion Criteria:

patients with clinically diagnosed solid tumors, including but not limited to recurrent head and neck
cancer, glioma, pancreatic cancer, osteosarcoma, etc.; The selected subjects need to sign the informed
consent.

Exclusion Criteria:

Pregnant women; renal failure (serum Cr>3mg/dl); Patients with claustrophobia;

Contacts and Locations Go to 

No Contacts or Locations Provided

More Information Go to 

Responsible Party:
Tongji Hospital

ClinicalTrials.gov Identifier:
NCT05538676     History of Changes

Other Study ID Numbers:

2022S150

First Posted:
September 14, 2022    Key Record Dates

Last Update Posted:

October 20, 2022

Last Verified:
August 2022

Individual Participant Data (IPD) Sharing Statement:

Plan to Share IPD:

Undecided

Studies a U.S. FDA-regulated Drug Product:

No

Studies a U.S. FDA-regulated Device Product:

No

Keywords provided by Tongji Hospital:

solid tumor BPA-PET